The BioRegion of Catalonia: What’s Behind the European Country with More Pharma Companies per Capita?

Jan 4, 2018

Last autumn, Barcelona hosted the CPhI Worldwide for the first time, and it was a record-breaking year for the event. In their article, Nuria Pelaez, Anna Rovira and Silvia Labe of Biocat Communication Unit show that although many international investors are not aware of this thriving life sciences cluster, the Bioregion of Catalonia has undergone unprecedented capitalisation of life sciences companies during the last three years, growing at more than 80% annually. ...

Read More

The Rise of Cellular Immunotherapy and Global IP Strategies

Jan 4, 2018

We are at the beginning of a new age in cancer therapy. With a large and growing number of patents and applications in this space, we can expect a large amount of patent litigation in the years to come as companies look to safeguard their market share. Frances Salisbury and Adam Gregory of Mewburn Ellis LLP look into the recent FDA approvals, an important landmark in cellular immunotherapy. ...

Read More

Preparing for IDMP: The Latest Advice on How to Ensure a Smooth Transition

Jan 4, 2018

The forthcoming ISO IDMP standards governing pharmaceutical product information recording have far-reaching implications for the way companies capture, collate, organise and report a very wide range of operational data. Master data management as an approach offers an efficient, definitive way to cope with this. Sonia Monahan of AMPLEXOR International explains in her article how companies can ensure they derive maximum payback from any new system investments. ...

Read More

Expanding Markets: Where Next? A Regional Regulatory Roundup

Jan 4, 2018

Globalisation and the growing efforts to standardise submission requirements and formats internationally continue to open up new markets for life sciences companies. Yet, there are still significant differences in requirements between regions and individual nations. With this in mind, Kimty Bui-Van of ProductLife Group assesses current regulatory climates in four markets with strategic appeal: Benelux, the Baltics, Canada, and South Africa. ...

Read More

Got Diversity? Of Course You Do. Now, What Are You Going to Do With It?

Jan 4, 2018

In her piece, Rosalie Harrison, an International Management Consultant with Borderless, addresses the benefits of inclusion & diversity. She tells us that inclusion is the method in which your organisation will leverage this diversity to achieve real business impact. Apparently, the concept of inclusion is often painfully misconstrued, although it remains the best way to harness diversity for business success. ...

Read More